Eglidin Tablets 4 mg (Irso-gladin Maleate)

Adult dose

1) Gastric ulcer (Adults) Administer 4mg of irsogladine maleate orally once daily. 2) Improvement of gastric mucosal lesions (erosion, bleeding, redness, and edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis (Adults) Administer 4mg of irsogladine maleate orally in 1~2 divided doses daily.

This medication contains lactose, so it should not be used by individuals with a genetic disorder that prevents lactose digestion. It is important to periodically check liver health status as this medication may cause liver function abnormalities. Gastrointestinal and skin-related side effects such as constipation, rash, itching, and diarrhea may occur; report any unusual symptoms to healthcare professionals immediately. Dizziness or drowsiness may rarely occur, so caution is advised when driving or operating machinery. In the elderly, physical function may be weakened; thus, it is important to start at a lower dosage and observe closely. Women who are pregnant or may become pregnant should only use this medication if the benefits outweigh the risks during treatment. Women who are breastfeeding should avoid taking this medication if possible, or if taken, consider stopping breastfeeding as this medication may be transmitted in breast milk. The safety of this medication in children has not been sufficiently established, so caution should be exercised.

• Abnormal liver function
• elevated ALT (GPT)
• elevated AST (GOT)
• constipation
• rash
• itching
• diarrhea
• elevated ALP
• nausea
• vomiting

This medication should be stored in a tightly sealed container to protect it from exposure to air and moisture, preferably at room temperature between 1 to 30 degrees Celsius. This storage method helps maintain the medication's effectiveness for a longer duration.

Appearance

White round tablet

Package unit

Bottle - 30 tablets/bottle, Bottle - 100 tablets/bottle